The emerging treatment of this peptide represents a exciting advance in the care of the condition. Distinct from existing medications, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – providing enhanced blood sugar control and potential weight loss. Sc